Expression and characterization of a chimeric bispecific antibody against fibrin and against urokinase-type plasminogen activator

This publication has 44 references indexed in Scilit:

• Comparative efficiencies of bispecific F(ab′γ)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fcγ receptors
  Cancer Immunology, Immunotherapy, 1992
• Therapeutic Effect of Ansamitocin Targeted to Tumor by a Bispecific Monoclonal Antibody
  Japanese Journal of Cancer Research, 1992
• Conjugation and evaluation of 7E3 x P4B6, a chemically crosslinked bispecific F(ab')2 antibody which inhibits platelet aggregation and localizes tissue plasminogen activator to the platelet surface
  Bioconjugate Chemistry, 1992
• Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
  The Journal of Experimental Medicine, 1992
• T cell targeting in cancer therapy
  Cancer Immunology, Immunotherapy, 1991
• A novel strategy for producing chimeric bispecific antibodies by gene transfection
  Biochemical and Biophysical Research Communications, 1989
• Tumour therapy with vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and vinca alkaloids
  International Journal of Cancer, 1988
• Transfectomas Provide Novel Chimeric Antibodies
  Science, 1985
• Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites
  Molecular Immunology, 1983
• Avidin-biotin affinity columns. General methods for attaching biotin to peptides and proteins
  Journal of the American Chemical Society, 1978